Gsk (GSK) Dividends Paid - Common (2009 - 2026)

Gsk's Dividends Paid - Common history runs 18 years deep, the most recent figure standing at -$866.9 million for Q1 2026.

• In Q1 2026, Dividends Paid - Common fell 12.46% year-over-year to -$866.9 million; the TTM figure through Mar 2026 stood at -$1.7 billion (down 42.76% YoY), while the FY2025 annual figure was $3.4 billion, up 8.21% from the prior year.
• Dividends Paid - Common was -$866.9 million for Q1 2026 at Gsk, down from -$520.1 million in the prior quarter.
• In the past five years, Dividends Paid - Common ranged from a high of $6.0 billion in Q4 2022 to a low of -$1.3 billion in Q1 2022.
• Historically, Dividends Paid - Common has averaged -$5.1 million across 5 years, with a median of -$167.9 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Dividends Paid - Common jumped 1976.03% in 2022, then plunged 216.57% in 2025.
• A 5-year view of Dividends Paid - Common shows it stood at $6.0 billion in 2022, then plunged by 101.6% to -$96.8 million in 2023, then tumbled by 69.7% to -$164.3 million in 2024, then slumped by 216.57% to -$520.1 million in 2025, then tumbled by 66.68% to -$866.9 million in 2026.
• The last three Dividends Paid - Common figures came in at -$866.9 million (Q1 2026), -$520.1 million (Q4 2025), and -$133.6 million (Q3 2025), per Business Quant data.